The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. Bacterial infection of the lower respiratory tract contributes to approximately 50% of COPD exacerbations. Even during periods of stable lung function, the lung harbors a community of bacteria, termed the microbiome. The role of the lung microbiome in the pathogenesis of COPD remains unknown. The COPD lung microbiome, like the healthy lung microbiome, appears to reflect microaspiration of oral microflora. Here we describe the COPD lung microbiome of 22 patients with Moderate or Severe COPD compared to 10 healthy control patients. The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid. Sequences were analyzed using mothur, Ribosomal Database Project, Fast UniFrac, and Metastats. Our results showed a significant increase in microbial diversity with the development of COPD. The main phyla in all samples were Actinobacteria, Firmicutes, and Proteobacteria. Principal coordinate analyses demonstrated separation of control and COPD samples, but samples did not cluster based on disease severity. However, samples did cluster based on the use of inhaled corticosteroids and inhaled bronchodilators. Metastats analyses demonstrated an increased abundance of several oral bacteria in COPD samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbiome, including the mycobiome, is largely dependent on the area of the body, and may be altered during disease (Pragman et al., 2010; Mukherjee et al., 2014; Gouba and Drancourt, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Pragman et al., 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“uchime implemented in mothur [37] were used to truncate low-quality sequences and remove chimeras, respectively.”
MethodMuyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429 · cited 1×
“PCR amplification using 16S rRNA gene primers specific to the constant regions flanking the V3 region [35,36] was performed using 20 cycles.”
MethodMultiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875 · cited 1×
“For PCoA analyses, sequences were dereplicated and ClustalW was used to align the dereplicated sequences [38].”
MethodThe Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 2×
“To minimize effects of random sequencing errors, we used RDP Pipeline [4] to eliminate (a) sequences that did not appropriately match the PCR primer and the barcode at the beginning of a read, (b) sequence reads with ,50 bases after the proximal PCR primer if they terminated before reaching the distal”
MethodDewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C. R., Yu, W.-H., Lakshmanan, A., & Wade, W. G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00542-10 · Cited by 3,352
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 1×
“The microbiome in early childhood may play a role in the development of asthma [8], while specific components of the microbiome are associated with chronic asthma in adulthood [9].”
BackgroundImproved extraction of PCR-quality community DNA from digesta and fecal samples
Yu, Z., & Morrison, M. (2004) · BioTechniques · doi:10.2144/04365st04 · Cited by 1,664 · cited 1×
“We used a previously described protocol [33] for DNA isolation that included bead beating to lyse bacterial cells, followed by precipitation with isopropanol and digestion with RNase.”
MethodStatistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,586 · cited 1×
“Metastats [40] was used to detect differentially abundant taxa using taxonomic data from RDP Classifier controlling the false discovery rate at 10% for each level of the taxonomy.”
MethodMicrobiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502 · cited 1×
“showed that the mouse microbiome helps regulate the immune function necessary to respond to Influenza A virus infection [12].”
BackgroundTopographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144 · cited 4×
“[7] who noted that the bacteria in the BALF arise from upper respiratory tract bacteria, likely through a combination of microaspiration and bronchoscopic carryover during sampling.”
BackgroundInfluential
Cited by
Items 201–300 of 445
Dickson, R. P., Huang, Y. J., Martínez, F. J., & Huffnagle, G. B. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1573ed · Cited by 29
Kraková, L., Šoltýs, K., Puškárová, A., Bučková, M., Jeszeová, L., Kucharík, M., Budiš, J., Orovčík, Ľ., Szemes, T., & Pangallo, D. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14312 · Cited by 26
“The bacterial communities of the lung area and the pleura of the mummy contained the same phyla (Actiomycetes and Firmicutes) as the microbiome of living humans (Pragman et al., 2012), though the major genera were quite different.”
BackgroundPragman, A. A., Knutson, K. A., Gould, T. J., Hodgson, S. W., Isaacson, R. E., Reilly, C., & Wendt, C. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219962 · Cited by 26
Self-citationSignificance of the Microbiome in Chronic Obstructive Pulmonary Disease
Martínez, F. J., Erb‐Downward, J. R., & Huffnagle, G. B. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-204aw · Cited by 27
The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression
Souza, V. G. P., Forder, A., Pewarchuk, M. E., Telkar, N., de Araújo, R. P., Stewart, G. L., Vieira, J., Reis, P. P., & Lam, W. L. (2023) · Cells · doi:10.3390/cells12242801 · Cited by 31
“The development of COPD is associated with increased diversity of the microbiome, in particular, of Firmicutes in more severe COPD [107,108].”
BackgroundSymptom-related sputum microbiota in stable chronic obstructive pulmonary disease
Diao, W., Shen, N., Du, Y., Erb‐Downward, J. R., Sun, X., Guo, C., Qian, K., Huffnagle, G. B., Gyetko, M. R., & He, B. (2018) · International Journal of COPD · doi:10.2147/copd.s167618 · Cited by 25
Niemeier‐Walsh, C., Ryan, P., Meller, J., Ollberding, N. J., Adhikari, A., & Reponen, T. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244341 · Cited by 26
“To our knowledge, there have been no previous studies that have documented a significant difference in the bacterial diversity of the lower respiratory tract between genders in asthmatic subjects [6], although a few studies showed respiratory bacterial microbiota and individual bacterial variability in lung cancer, br…”
ResultCheng, J., Zhou, L., & Wang, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1296295 · Cited by 24
Rutebemberwa, A., Stevens, M. J., Perez, M. J., Smith, L. P., Sanders, L., Cosgrove, G. P., Robertson, C. E., Tuder, R. M., & Harris, J. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111150 · Cited by 24
“Our results are in concordance with several other clinical studies that have reported the presence of lung microbiota in patients with COPD [12,48–51].”
ResultWalsh, D. M., McCullough, S. D., Yourstone, S., Jones, S., Cairns, B. A., Jones, C. D., Jaspers, I., & Díaz-Sánchez, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173848 · Cited by 25
Gram‐negative microbiota is related to acute exacerbation in children with asthma
Kim, Y. H., Jang, H., Kim, S. Y., Jung, J. H., Kim, G. E., Park, M. R., Hong, J. Y., Kim, M. N., Kim, E. G., Kim, M. J., et al. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12069 · Cited by 23
Malhotra, R., & Olsson, H. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1000865 · Cited by 25
“[35] reported a higher level of microbial diversity among the COPD subjects compared Immunology, genetics & microbiota in the COPD pathophysiology Perspective”
BackgroundBourne, S. C., Cohet, C., Kim, V., Barton, A. L., Tuck, A., Aris, E., Mesía-Vela, S., Devaster, J., Ballou, W. R., Clarke, S. C., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004546 · Cited by 26
Feng, N., Han, X., Peng, D., Geng, F., Li, Q., Pan, C., Wang, H., Pan, Y., & Tan, L. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2334588 · Cited by 24
“Some researches focused on the involvement of periodontal pathogens in the development of COPD [7–9].”
BackgroundHoisington, A. J., Stearns‐Yoder, K. A., Kovacs, E. J., Postolache, T. T., & Brenner, L. A. (2024) · Current Environmental Health Reports · doi:10.1007/s40572-024-00437-8 · Cited by 22
“The gut and lung microbiota and the oral and lung microbiota share some similar microbes, at least in the upper respiratory tract [169, 170].”
Chronic Obstructive Pulmonary Disease and Infection. Disruption of the Microbiome?
Sethi, S. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201307-212mg · Cited by 27
JTD special edition 'Hot Topics in COPD'-The microbiome in COPD.
Chambers, D. C., Gellatly, S. L., Hugenholtz, P., & Hansbro, P. M. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.11.08 · Cited by 25
“This is partly driven by increases in members of the phylum Firmicutes in patients with stable COPD (8,10,15,16).”
BackgroundAgarwal, D. M., Dhotre, D. P., Kumbhare, S. V., Gaike, A. H., Brashier, B. B., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-020-02155-9 · Cited by 26
Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians
Luo, L., Tang, J., Du, X., & Li, N. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107586 · Cited by 27
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
O’Shaughnessy, M., Sheils, O. M., & Baird, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512296 · Cited by 25
Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
Nucera, F., Bello, F. L., Shen, S., Ruggeri, P., Coppolino, I., Stefano, A. D., Stellato, C., Casolaro, V., Hansbro, P. M., Adcock, I. M., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200819145327 · Cited by 21
Periodontal status and lung function decline in the community: the Hisayama study.
Takeuchi, K., Matsumoto, K., Furuta, M., Fukuyama, S., Takeshita, T., Ogata, H., Suma, S., Shibata, Y., Shimazaki, Y., Hata, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31610-3 · Cited by 20
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 26
Nasal Microbiome and Its Interaction with the Host in Childhood Asthma
Zeng, Y., & Liang, Q. (2022) · Cells · doi:10.3390/cells11193155 · Cited by 20
Suzuki, R., Kamio, N., Kaneko, T., Yonehara, Y., & Imai, K. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13369 · Cited by 20
SUZUKI, R., Kamio, N., Sugimoto, K., Maruoka, S., Gon, Y., Kaneko, T., Yonehara, Y., & Imai, K. (2022) · In Vivo · doi:10.21873/invivo.12749 · Cited by 20
Kayongo, A., Bartolomaeus, T. U. P., Birkner, T., Markó, L., Löber, U., Kigozi, E., Atugonza, C., Munana, R., Mawanda, D., Sekibira, R., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02139-21 · Cited by 20
“Alternatively, Campylobacter microaspiration might inoc-ulate the airways and drive the establishment of a more stable ecological niche in COPD (35).”
BackgroundCrosstalk between the lung microbiome and lung cancer
Meng, Y., Mao, Y., Tang, Z., Qiu, X., Bajinka, O., Tan, Y., & Song, Z. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106062 · Cited by 21
The Fungal and Bacterial Interface in the Respiratory Mycobiome with a Focus on Aspergillus spp.
Rozaliyani, A., Antariksa, B., Nurwidya, F., Zaini, J., Setianingrum, F., Hasan, F. N., Nugrahapraja, H., Yusva, H., Wibowo, H., Bowolaksono, A., et al. (2023) · Life · doi:10.3390/life13041017 · Cited by 22
“The previous study investigated the usage of bronchodilators, and corticosteroid inhalation might be associated with altering the lung microbiome [121].”
BackgroundLower airway microbiota in COPD and healthy controls
Tangedal, S., Nielsen, R., Aanerud, M., Drengenes, C., Husebø, G. R., Lehmann, S., Knudsen, K. S., Hiemstra, P. S., & Eagan, T. (2024) · Thorax · doi:10.1136/thorax-2023-220455 · Cited by 23
Kou, Z., Liu, K., Qiao, Z., Wang, Y., Li, Y., Li, Y., Yu, X., & Han, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1407439 · Cited by 20
Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation
Wang, Z., Pu, Q., Huang, C., & Wu, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63046-1_18 · Cited by 20
The lung microbiome: the perfect culprit for COPD exacerbations?
Gomez, C., & Chanez, P. (2016) · European Respiratory Journal · doi:10.1183/13993003.00270-2016 · Cited by 20
Lineros, R., Fernández-Delgado, L., Vega, A. P., Chacón, P., Doukkali, B., Monteseirín, J., & Perez, D. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051243 · Cited by 19
“Research studies have shown that sputum samples contain different types of microorganisms compared to bronchoalveolar samples, and it has been confirmed that the lungs of COPD patients have unique microbiomes that differ from healthy individuals in terms of bacterial composition [20,21].”
BackgroundHuang, Q., Wu, X., Gu, Y., Wang, T., Zhan, Y., Chen, J., Zeng, Z., Lv, Y., Zhao, J., & Xie, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839259 · Cited by 19
“, 2020); (Pragman et al., 2012; Ren et al., 2018; Wang et al., 2019), which we speculated might partially interpreted the upregulated BCAAs in lungs.”
BackgroundThe human microbiota: a new direction in the investigation of thoracic diseases.
Hui, A. W. H., Lau, H.-W., Chan, T. H.-T., & Tsui, S. K. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.07.41 · Cited by 19
“In contrast to an earlier study (19), a more recent and larger study comparing the lung microbiome in moderate and severe COPD patients with normal subjects yielded contradictory results that there is a higher level of microbial diversity in the lung and this discrepancy may be explained by age differences (18).”
BackgroundResultDimon, M. T., Wood, H. M., Rabbitts, P. H., & Arron, S. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064546 · Cited by 17
“These studies have enabled the study of normal and diseased human intestinal, respiratory, skin and urogenital microbiota[2,3,4], identification of novel viruses in diseases such as human Merkel cell carcinoma and acute hemorrhagic fever[5,6] and in a variety of animal diseases including avian…”
BackgroundChang, C. H., Zhu, H., Shen, N., Chen, Y., He, B., Zhao, J., & Yao, W.-Z. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.898043 · Cited by 18
The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma
Lu, J., Xiong, L., Zhang, X., Liu, Z., Wang, S., Zhang, C., Zheng, J., Wang, G., Zheng, R., Simpson, J. L., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/3890601 · Cited by 19
“Interestingly, in patients with COPD, a similar discrepancy where increased or decreased diversity of lower airway microbiota is reported [12, 54].”
Short term dynamics of the sputum microbiome among COPD patients
Sinha, R., Weissenburger-Moser, L. A., Clarke, J., Smith, L. M., Heires, A. J., Romberger, D. J., & LeVan, T. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191499 · Cited by 17
Cai, L., Gao, P., Wang, Z., Dai, C., Ye, N., İlkit, M., Xue, X., Xiao, J., & Chen, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988708 · Cited by 18
“The lung microbiome is associated with immune activation and regulation (22); it is also known to diverge substantially between healthy (23) and diseased states (24, 25).”
BackgroundAlsayed, A. R., Abed, A. I., Jarrar, Y. B., Alshammari, F., Alshammari, B., Basheti, I. A., & Zihlif, M. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062118 · Cited by 17
“According to earlier studies, the diversity of the lung microbiota has been found to be greater [41], decreased [38], or equivalent [37] in patients with COPD, compared with healthy controls.”
ResultLoss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD
Sze, M. A., Utokaparch, S., Elliott, W. M., Hogg, J. C., & Hegele, R. G. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006677 · Cited by 17
Advances in Machine Learning for Processing and Comparison of Metagenomic Data
Bouchot, J.-L., Trimble, W. L., Ditzler, G., Lan, Y., Essinger, S., & ROSEN, G. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405926-9.00014-9 · Cited by 17
“Microbes are found at almost every interface of the body, including skin, mouth, airways, and even places like the lungs and amniotic fluid once thought to be sterils [12, 13].”
BackgroundCharacterization of throat microbial flora in smokers with or without COPD
Diao, W., Shen, N., Du, Y., Qian, K., & He, B. (2017) · International Journal of COPD · doi:10.2147/copd.s140243 · Cited by 17
“8,17 Our results indicated that the OTUs, Shannon and inverse Simpson indexes showed a decreased trend in COPD, which were also similar to those of the lower airway.”
Obolewski, K., & Glińska‐Lewczuk, K. (2020) · Ecological Engineering · doi:10.1016/j.ecoleng.2020.105948 · Cited by 18
Caro, J. C. L., Santibáñez, M., Rivero, J. L. G., Villanueva, M. Á., Sainz, J., GonzálezAstorqui, P., Hierro, M., Porres, M. R., Parás‐Bravo, P., Mira, Á., et al. (2019) · Respiration · doi:10.1159/000501988 · Cited by 16
Qi, Y.-J., Sun, X.-J., Wang, Z., Bin, Y.-F., Li, Y., Zhong, X., Bai, J., Deng, J., & He, Z. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000677 · Cited by 16
Lung microbiome – a modern knowledge
Siwicka-Gieroba, D., & Czarko-Wicha, K. (2020) · Central European Journal of Immunology · doi:10.5114/ceji.2020.101266 · Cited by 21
Zinter, M. S., Versluys, B. A. B., Lindemans, C. A., Mayday, M. Y., Reyes, G. A., Sunshine, S., Chan, M., Fiorino, E. K., Cancio, M., Prevaes, S. M. P. J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm8646 · Cited by 16
Feng, Z., Li, Q., Liu, S.-R., Du, X., Wang, C., Nie, X., Wang, W., & Sun, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.204934 · Cited by 16
“Such observations appeared to be different from other studies.[4] A potential explanation is that microbiome in airways may vary with local environment and individual status, especially in those elders (median age was 64 years) with pulmonary space occupying lesions.”
ResultCheng, Z.-X., & Zhang, J. (2024) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2023.0442 · Cited by 20
“61,65,66 Taken together, changes in microbial richness and evenness indicate diminished commensal microbiota and proliferated potentially pathogenic microbiota, resulting in a deviated and restricted pattern in the respiratory microbiome of severe COPD patients.”
BackgroundZhou, Z., Lv, Y., Zuo, A., Zhu, X., Xu, Y., Zuo, L., Xu, H., Liu, S., Zhang, Y., Weng, S., et al. (2025) · hLife · doi:10.1016/j.hlife.2025.05.008 · Cited by 16
“Additionally, a decreased prevalence of lung cancer was demonstrated in germ-free mice [130].”
Metabolomics of Respiratory Diseases
Moitra, S., Bandyopadhyay, A., & Lacy, P. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_614 · Cited by 17
Lower respiratory tract microbiome composition and community interactions in smokers
Campos, M., Cickovski, T., Fernandez, M., Jaric, M., Wanner, A., Holt, G. E., Donna, E., Mendes, E. S., Silva‐Herzog, E., Schneper, L. M., et al. (2023) · Access Microbiology · doi:10.1099/acmi.0.000497.v3 · Cited by 16
“Studies on the LRT bacterial composition in cases of smoking-associated diseases such as chronic obstructive pulmonary disease (COPD) [16, 18–20], pulmonary fibrosis [21] and lung cancer [22, 23] have shown distinct differences compared with non-diseased subjects.”
BackgroundPragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. H., & Isaacson, R. E. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03320-14 · Cited by 15
“Furthermore, our study demonstrated changes in the lung microbiota related to inhaled corticosteroid use (2).”
BackgroundResultSelf-citationMcDaneld, T. G., Workman, A. M., Chitko-McKown, C. G., Kuehn, L. A., Dickey, A. M., & Bennett, G. L. (2022) · Frontiers in Microbiomes · doi:10.3389/frmbi.2022.1051241 · Cited by 14
“While the relative abundance of Lactobacillales is low in the HRT calves evaluated, previous literature has identified Lactobacillales in the microbiome of the URT of turkeys and the lung and in the sputum of children with pneumonia (Pragman et al., 2012; Pettigrew et al., 2016; Kursa et al., 2021).”
Tu, J.-B., Liao, W.-J., Long, S.-P., Li, M.-P., & Gao, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371371 · Cited by 14
Koceva, H., Amiratashani, M., Akbarimoghaddam, P., Hoffmann, B., Zhurgenbayeva, G., Gresnigt, M. S., Marcelino, V. R., Eggeling, C., Figge, M. T., Amorim, M. J., et al. (2025) · Open Biology · doi:10.1098/rsob.240231 · Cited by 16
“For example, the overgrowth of certain gut bacteria like Enterobacteriaceae has been correlated with frequent COPD exacerbations [101].”
Potential Association Between Changes in Microbiota Level and Lung Diseases: A Meta-Analysis
Chai, L., Wang, Q., Si, C., Gao, W., & Zhang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.723635 · Cited by 14
Knudsen, K. S., Lehmann, S., Nielsen, R., Tangedal, S., Haaland, I., Hiemstra, P. S., & Eagan, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262082 · Cited by 15
Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease
Gao, J., Yang, Y., Xiang, X., Zheng, H., Yi, X., Wang, F., Liang, Z., Chen, D., Shi, W., Wang, L., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02805-2 · Cited by 15
“Mounting evidence has revealed a diverse airway microbial ecosystem or microbiome associated with COPD characteristics [7–12].”
BackgroundAn update on the pharmacotherapeutic management of lower respiratory tract infections
Cazzola, M., Rogliani, P., Aliberti, S., Blasi, F., & Matera, M. G. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1328497 · Cited by 15
“Interestingly, the lung microbiome is not only dependent on the disease but also on the type of medication usage such as inhaled corticosteroids and long-acting bronchodilators [52].”
BackgroundRan, Z., Liu, J., Wang, F., Xin, C., Shen, X., Zeng, S., Song, Z., & Xiong, B. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.103.16 · Cited by 12
Zdziarski, P., Paściak, M., & Gamian, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.636180 · Cited by 14
“Only one study shows lung microbiome alteration in patients treated with ICS (Pragman et al., 2012).”
BackgroundAlterations of gut microbiome in eosinophilic chronic rhinosinusitis
Liang, Y., Zhang, C., Xiong, X., Mao, X., Sun, P., Yue, Z., Wang, W., Xie, R., & Zhang, G. (2024) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-024-08931-3 · Cited by 13
“The evidence from previous studies suggested that Proteobacteria was significantly increased in chronic inflammatory diseases, such as nonalcoholic fatty liver disease, IBD, asthma and COPD [16–19].”
KavianFar, A., Taherkhani, H., Lanjanian, H., Aminnezhad, S., Ahmadi, A., Jamalkandi, S. A., & Masoudi‐Nejad, A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42719 · Cited by 11
“Recent studies showed that microbial diversity is a key feature of a “ healthy ” microbiome and the presence or absence of specific microbial taxa plays a critical role in disease [10].”
The contribution of respiratory microbiome analysis to a treatable traits model of care
Taylor, S., O’Farrell, H. E., Simpson, J. L., Yang, I. A., & Rogers, G. B. (2018) · Respirology · doi:10.1111/resp.13411 · Cited by 12
Repeated bronchoscopy in health and obstructive lung disease: is the airway microbiome stable?
Nielsen, R., Xue, Y., Jonassen, I., Haaland, I., Kommedal, Ø., Wiker, H. G., Drengenes, C., Bakke, P. S., & Eagan, T. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01687-0 · Cited by 11
Differences of the Nasal Microbiome and Mycobiome by Clinical Characteristics of COPD Patients
Baumgartner, M. A., Li, C., Kuntz, T. M., Nurhussien, L., Synn, A. J., Sun, W. Y., Kang, J., Lai, P. S., Wilkinson, J. E., & Rice, M. B. (2022) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0267 · Cited by 11
Mechanisms and markers of lung ageing in health and disease
Miller, Z., Twardowski, L.-M., Reader, B. F., Rojas, M. M., Lehmann, M., & Mora, A. L. (2025) · European Respiratory Review · doi:10.1183/16000617.0233-2024 · Cited by 14
“In addition, Actinobacteria , Firmicutes and Proteobacteria have been found to be the most prevalent species in COPD BALF [191].”
Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
Ezechukwu, H. C., Diya, C. A., Egoh, I. J., Abiodun, M. J., Grace, J.-U. A., Okoh, G. R., Adu, K. T., & Adegboye, O. A. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211032453 · Cited by 15
Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection
Zhang, Y., Ran, Z., Tian, M., Zhou, Y., Yang, J., Yin, J. J., Lu, D., Li, R. Q., & Zhong, J. S. (2019) · Infection and Immunity · doi:10.1128/iai.00421-19 · Cited by 11
“Enrichment of Proteobacteria has also been identified in the lungs of chronic obstructive pulmonary disease (COPD) patients compared with those of healthy smokers and nonsmokers (54, 55).”
Plant-based Remedies with Reference to Respiratory Diseases – A Review
Popova, A. T., Mihaylova, D. S., & Спасов, А. А. (2021) · The Open Biotechnology Journal · doi:10.2174/1874434602015010046 · Cited by 12
Les bactéries anaérobies, ces inconnues du microbiote pulmonaire
Guilloux, C.-A., Lamoureux, C., & Héry-Arnaud, G. (2018) · médecine/sciences · doi:10.1051/medsci/20183403014 · Cited by 12
“Hery_Synthese.indd 258 Hery_Synthese.indd 258”
Aerodigestive dysbiosis in children with chronic cough
Kazachkov, M. Y., Kapoor, B. C., Malecha, P. W., Wu, B. G., Li, Y., Levine, J. J., Erkman, J. L., Fitzgerald, K. C., Moy, L. C., & Segal, L. N. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.24115 · Cited by 11
“Of note, the use of high doses of inhaled steroids in asthma group could potentially influence these results.(24,25) In the cohort presented here, approximately 50% of the subjects were treated with inhaled steroids.”
BackgroundYeh, J., Lin, C., & Kao, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229484 · Cited by 10
Informed development of a multi‐species biofilm in chronic obstructive pulmonary disease
Short, B., Delaney, C., Johnston, W., Litherland, G. J., Lockhart, J. C., Williams, C., Mackay, W. G., & Ramage, G. (2024) · Apmis · doi:10.1111/apm.13386 · Cited by 9
“The findings of these studies are in agreement and report compositional changes in the microbiome of COPD patients in comparison with healthy controls [8 – 11].”
ResultPei, G., Guo, L., Liang, S., Chen, F., Ma, N., Bai, J., Deng, J., Li, M., Qin, C., Feng, T., et al. (2024) · Respiration · doi:10.1159/000538911 · Cited by 10
“Pragman et al. [8] found that lung microbial diversity increased signi fi cantly with the progression of COPD.”
Ham, S., Oh, Y., & Roh, T. (2019) · Genomics & Informatics · doi:10.5808/gi.2019.17.1.e2 · Cited by 9
“While mild-to-moderate COPD exhibits higher diversity in the bacterial population [33], severe COPD shows lower diversity [34].”
Use of inhaled corticosteroids in COPD: improving efficacy
Yang, I. A., Shaw, J. G., Goddard, J. R., Clarke, M., & Reid, D. W. (2016) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1151789 · Cited by 11
“A cross-sectional study of 22 patients with moderate-to-severe COPD found that ICS influenced the bacterial community composition of the lung microbiome [91].”
BackgroundD’Argenio, V., Casaburi, G., Precone, V., Moccia, L. G., Postiglione, I., Bocchino, M., & Sanduzzi, A. (2018) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v35i4.7061 · Cited by 10
“Notably, a NGS-based approach has recently been used to investigate the microbial communities of the upper and lower airways of patients affected by different respiratory diseases (22-27).”
MethodEvidence for polymicrobial communities in explanted vascular filters and atheroma debris
Ellis, J. E., Heuser, R. R., Missan, D. S., Martinez, D., Heningburg, A. M., Shabilla, M., Schwartz, R. S., & Fry, S. E. (2017) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.04.001 · Cited by 11
Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
Singh, S., Pragman, A. A., & Segal, L. N. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2024ed · Cited by 9
Self-citationBaldi, S., Fabbrizzi, A., Gloria, L. D., Pallecchi, M., Nannini, G., D’Ambrosio, M., Luceri, C., Bartolucci, G., Ramazzotti, M., Fontana, G. A., et al. (2024) · Lung · doi:10.1007/s00408-024-00681-7 · Cited by 9
“Consisted with our findings, a significant increase in oral alpha-diversity has been reported in patients with asthma [44] or COPD [45] compared with HC.”
BackgroundResultRogers, G. B. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170043 · Cited by 10
Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis
Chen, D., Zeng, Q., Liu, L., Zhou, Z., Qi, W., Yu, S., & Zhao, L. (2023) · International Journal of COPD · doi:10.2147/copd.s405310 · Cited by 9
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
Scialò, F., Vitale, M., D’Agnano, V., Mariniello, D. F., Perrotta, F., Castaldo, A., Campbell, S. F. M., Pastore, L., Cazzola, M., & Bianco, A. (2023) · Lung · doi:10.1007/s00408-023-00645-3 · Cited by 9
“Fifty percent of patients affected by COPD harbour pathogens such as Streptococcus pneumoniae (Sp), Haemophilus influenzae (Hi), and Moraxella catarrhalis, and their presence promotes a state of chronic inflammation leading to COPD and COPD exacerbations [20, 21].”
BackgroundExact variance component tests for longitudinal microbiome studies
Zhai, J., Knox, K. S., Twigg, H. L., Zhou, H., & Zhou, J. J. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22185 · Cited by 8
An Unclassified Microorganism: Novel Pathogen Candidate Lurking in Human Airways
Fukuda, K., Yatera, K., Ogawa, M., Kawanami, T., Yamasaki, K., Noguchi, S., Murphy, R. S., Mukae, H., & Taniguchi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103646 · Cited by 8
Shi, Y., Yang, J., Tian, T., Li, S., & Xie, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487393 · Cited by 7
“…lavage fluid of moderate and severe COPD patients, found that the microbial community structure in the lungs of these two patient groups had changed, and Firmicutes, Proteobacteria and Actinobacteria were abundant in the lower respiratory tract of these patients (Pragman et al., 2012).”
The Microbiome in Asthma Heterogeneity: The Role of Multi‐Omic Investigations
Huang, Y. J. (2025) · Immunological Reviews · doi:10.1111/imr.70015 · Cited by 10
La BPCO : une maladie qui commence précocement
Margelidon-Cozzolino, V., Chbini, K., Freymond, N., Devouassoux, G., Belaaouaj, A., & Pachéco, Y. (2015) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2015.08.002 · Cited by 9
“La nature de es altérations du microbiome n’a pas encore été clairement tablie, certaines études ont montré une diminution de la iversité bactérienne [50,53], d’autres à l’inverse une augentation de diversité [51,52,54], et ceci est certainement ié à l’âge des patients [52], au manque d’homogénéité des opulations étud…”
Agarwal, D. M., Dhotre, D. P., Patil, R., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00196 · Cited by 9
“Pragman et al. revealed that anaerobic bacteria from the phylum Fusobacteria and Bacteroidetes and genus Clostridium are present in the air-rich environment of lungs of COPD subjects (47).”
The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?
Gates, K. L., & Martínez, F. J. (2016) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.1.2015.0174 · Cited by 7
Druzhinin, V. G., Matskova, L. V., Demenkov, P., Сергеевич, Д. П., Volobaev, V. P., Minina, V. I., Викторович, Л. А., & Paradnikova, S. A. (2022) · Life · doi:10.3390/life12060830 · Cited by 9
“Different investigators report on the one hand, an increase in the representation of Streptococcus in the microbiota of patients with COPD compared to healthy controls [43,44] and on the other hand that no differences are observed in the abundance of this taxa with regard to this pathology [45–47].”
BackgroundWhole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes
Knudsen, K. S., Husebø, G. R., Nielsen, R., Paytuví-Gallart, A., Malinverni, R., Sanseverino, W., Lehmann, S., & Eagan, T. (2025) · Respiratory Research · doi:10.1186/s12931-025-03404-5 · Cited by 8
“These taxonomic entities have been identified as being correlated with chronic respiratory diseases affecting the lungs [14, 15, 20, 38, 50].”
Huang, H., Lin, C.-H., Lee, M., Huang, W., Sheu, C., Cheng, M., Lu, P., Huang, C., Yeh, Y., Yang, J., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107085 · Cited by 7
Mithradas, N., Sudhakar, U., Shanmugapriya, K., Jeddy, N., & Ram, S. (2024) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_277_24 · Cited by 6
“[11,12] Periodontitis‑associated pathogens could damage respiratory epithelium and promote respiratory pathogen infection by elevating the expression of a core mucin protein, Mucin 5AC (MUC5AC), in bronchial epithelial cells.”
Taherkhani, H., KavianFar, A., Aminnezhad, S., Lanjanian, H., Ahmadi, A., Jamalkandi, S. A., & Masoudi‐Nejad, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24775 · Cited by 7
Metadata
- Authors
- Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Isaacson, Richard E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-11
- Volume
- 7
- Issue
- 10
- Pages
- e47305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3469539
- OpenAlex
- W2077691383
- Cited by
- 437
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 29 · 2023: 20 · 2022: 37 · 2021: 50 · 2020: 39 · 2019: 26 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 28 · 2014: 39 · 2013: 20 · 2012: 2
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Minnesota
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- National Institutes of Health (n01hr096140-001)
- University of Illinois at Urbana-Champaign
- National Heart, Lung, and Blood Institute (N01 HR096140, N010HR-96140)
- National Institute of Allergy and Infectious Diseases (T32AI55433, T32AI055433)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- lung microbiome, chronic obstructive pulmonary disease, COPD exacerbations, bronchoalveolar lavage fluid, microbial diversity, oral bacteria, inhaled corticosteroids, inhaled bronchodilators, disease severity, actinobacteria, Firmicutes, Proteobacteria
- MeSH terms
- Adult, Aged, Bronchoalveolar Lavage Fluid, Chronic Disease, Female, Humans, Lung, Male, Middle Aged, RNA, Ribosomal, 16S, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Actinobacteria, Bacteroidetes, Fusobacteria, Metagenome, Acidobacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.